• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

没食子儿茶素没食子酸酯通过抑制 Twist/VE-钙黏蛋白/AKT 通路抑制人前列腺癌细胞 PC-3 中的血管生成拟态。

Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.

机构信息

Department of Cancer Preventive Material Development, College of Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.

Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.

出版信息

Int J Mol Sci. 2020 Jan 9;21(2):439. doi: 10.3390/ijms21020439.

DOI:10.3390/ijms21020439
PMID:31936664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7013924/
Abstract

Vasculogenic mimicry (VM) is the alternative process of forming vessel-like networks by aggressive tumor cells, and it has an important role in tumor survival, growth, and metastasis. Epigallocatechin-3-gallate (EGCG) is well known to have diverse bioactivities including anti-cancer effects. However, the efficacy of EGCG on VM is elusive. In this study, we explored whether and how EGCG affects VM in human prostate cancer (PCa) PC-3 cells. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Invasive and VM formation abilities were assessed by an invasion assay and a three-dimensional (3D) culture VM tube formation assay, respectively. Western blots were carried out. An immunofluorescence assay was performed to detect nuclear twist expression. EGCG effectively inhibited the invasive ability, as well as tubular channel formation, without affecting cell viability. EGCG significantly downregulated the expression of vascular endothelial cadherin (VE-cadherin) and its transcription factor, twist, N-cadherin, vimentin, phosphor-AKT, and AKT, but not phospho-erythropoietin-producing hepatocellular receptor A2 (EphA2) and EphA2. In addition, EGCG diminished the nuclear localization of twist. Treatment with SC79, an AKT activator, effectively rescued EGCG-inhibited VM formation. These results demonstrated for the first time that EGCG causes marked suppression of VM through inhibiting the twist/VE-cadherin/AKT pathway in human PCa PC-3 cells.

摘要

血管生成拟态(VM)是指侵袭性肿瘤细胞形成类似血管的网络的替代过程,它在肿瘤的存活、生长和转移中起着重要作用。表没食子儿茶素没食子酸酯(EGCG)具有多种生物活性,包括抗癌作用,这是众所周知的。然而,EGCG 对 VM 的疗效尚不清楚。在这项研究中,我们探讨了 EGCG 是否以及如何影响人前列腺癌(PCa)PC-3 细胞中的 VM。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定法测量细胞活力。通过侵袭测定和三维(3D)培养 VM 管形成测定分别评估侵袭和 VM 形成能力。进行了 Western blot 分析。进行了免疫荧光检测以检测核 twist 表达。EGCG 有效抑制了侵袭能力和管状通道形成,而不影响细胞活力。EGCG 显著下调了血管内皮钙黏蛋白(VE-cadherin)及其转录因子 twist、N-钙黏蛋白、波形蛋白、磷酸化 AKT 和 AKT 的表达,但不影响磷酸化红细胞生成素产生肝细胞受体 A2(EphA2)和 EphA2。此外,EGCG 减少了 twist 的核定位。用 AKT 激活剂 SC79 处理可有效挽救 EGCG 抑制的 VM 形成。这些结果首次表明,EGCG 通过抑制人类 PCa PC-3 细胞中的 twist/VE-cadherin/AKT 通路导致 VM 明显抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8fadffb14824/ijms-21-00439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/49d68d7c0516/ijms-21-00439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/d3886c2b8345/ijms-21-00439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8da5372362bb/ijms-21-00439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8c22c38b0853/ijms-21-00439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8fadffb14824/ijms-21-00439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/49d68d7c0516/ijms-21-00439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/d3886c2b8345/ijms-21-00439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8da5372362bb/ijms-21-00439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8c22c38b0853/ijms-21-00439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cc/7013924/8fadffb14824/ijms-21-00439-g005.jpg

相似文献

1
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.没食子儿茶素没食子酸酯通过抑制 Twist/VE-钙黏蛋白/AKT 通路抑制人前列腺癌细胞 PC-3 中的血管生成拟态。
Int J Mol Sci. 2020 Jan 9;21(2):439. doi: 10.3390/ijms21020439.
2
Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.血清通过 EphA2/VE-钙黏蛋白/AKT 通路促进 PC-3 人前列腺癌细胞中的血管生成拟态。
Life Sci. 2019 Mar 15;221:267-273. doi: 10.1016/j.lfs.2019.02.043. Epub 2019 Feb 21.
3
Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.白藜芦醇通过抑制 EphA2/ twist-VE 钙黏蛋白/AKT 通路抑制血清诱导的人前列腺癌 PC-3 细胞血管拟态形成。
Sci Rep. 2022 Nov 22;12(1):20125. doi: 10.1038/s41598-022-24414-z.
4
Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells.Sp1 在人前列腺癌细胞血管生成拟态中发挥关键作用。
Int J Mol Sci. 2022 Jan 25;23(3):1321. doi: 10.3390/ijms23031321.
5
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.重楼皂苷 I 通过 Twist1/VE-cadherin 通路抑制血管生成拟态的形成。
Cell Death Dis. 2018 Sep 5;9(9):906. doi: 10.1038/s41419-018-0902-5.
6
HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.低氧诱导因子-1α(HIF-1α)诱导食管癌细胞中血管内皮钙黏蛋白(VE-cadherin)的表达并调节血管生成拟态。
World J Gastroenterol. 2014 Dec 21;20(47):17894-904. doi: 10.3748/wjg.v20.i47.17894.
7
miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.微小RNA-27a-3p通过下调血管内皮钙黏蛋白表达和抑制上皮-间质转化来抑制肿瘤转移和血管生成拟态:Twist-1在肝癌中的重要作用
Sci Rep. 2016 Mar 16;6:23091. doi: 10.1038/srep23091.
8
HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.低氧诱导因子-2α通过调节Twist1与血管内皮钙黏蛋白启动子的结合来促进胰腺癌中血管生成拟态的形成。
Oncotarget. 2017 Jul 18;8(29):47801-47815. doi: 10.18632/oncotarget.17999.
9
Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.抗血管生成治疗通过血管生成拟态促进三阴性乳腺癌侵袭。
Cancer Biol Ther. 2017 Apr 3;18(4):205-213. doi: 10.1080/15384047.2017.1294288. Epub 2017 Feb 21.
10
Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.没食子酸表没食子儿茶素酯抑制人甲状腺癌细胞系的生长和上皮间质转化。
J Cell Physiol. 2013 Oct;228(10):2054-62. doi: 10.1002/jcp.24372.

引用本文的文献

1
Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials.表没食子儿茶素没食子酸酯的抗癌分子机制:临床试验的最新综述
Food Sci Nutr. 2025 Aug 1;13(8):e70735. doi: 10.1002/fsn3.70735. eCollection 2025 Aug.
2
Therapeutic Potential of Plant- and Marine-Derived Bioactive Compounds in Prostate Cancer: Mechanistic Insights and Translational Applications.植物和海洋来源的生物活性化合物在前列腺癌中的治疗潜力:机制见解与转化应用
Pharmaceuticals (Basel). 2025 Feb 20;18(3):286. doi: 10.3390/ph18030286.
3
Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.

本文引用的文献

1
Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.血清通过 EphA2/VE-钙黏蛋白/AKT 通路促进 PC-3 人前列腺癌细胞中的血管生成拟态。
Life Sci. 2019 Mar 15;221:267-273. doi: 10.1016/j.lfs.2019.02.043. Epub 2019 Feb 21.
2
(-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway.(-)-表没食子儿茶素没食子酸酯(EGCG)通过抑制 GRP78/NF-κB/miR-155-5p/MDR1 通路增强结直肠癌细胞对 5-FU 的敏感性。
J Agric Food Chem. 2019 Mar 6;67(9):2510-2518. doi: 10.1021/acs.jafc.8b06665. Epub 2019 Feb 20.
3
瘦素通过调节水通道蛋白-1促进乳腺癌细胞血管生成拟态。
Int J Mol Sci. 2024 May 10;25(10):5215. doi: 10.3390/ijms25105215.
4
L1CAM promotes vasculogenic mimicry formation by miR-143-3p-induced expression of hexokinase 2 in glioma.L1CAM 通过 miR-143-3p 诱导的己糖激酶 2 表达促进胶质瘤中的血管生成拟态形成。
Mol Oncol. 2023 Apr;17(4):664-685. doi: 10.1002/1878-0261.13384. Epub 2023 Feb 8.
5
Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.白藜芦醇通过抑制 EphA2/ twist-VE 钙黏蛋白/AKT 通路抑制血清诱导的人前列腺癌 PC-3 细胞血管拟态形成。
Sci Rep. 2022 Nov 22;12(1):20125. doi: 10.1038/s41598-022-24414-z.
6
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.植物化学物质抑制前列腺癌的作用机制研究进展。
Biomolecules. 2022 Sep 16;12(9):1306. doi: 10.3390/biom12091306.
7
Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells.Sp1 在人前列腺癌细胞血管生成拟态中发挥关键作用。
Int J Mol Sci. 2022 Jan 25;23(3):1321. doi: 10.3390/ijms23031321.
8
Prostate cancer: Therapeutic prospect with herbal medicine.前列腺癌:草药治疗前景
Curr Res Pharmacol Drug Discov. 2021 Jul 8;2:100034. doi: 10.1016/j.crphar.2021.100034. eCollection 2021.
9
Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis.微生物代谢产物脱氧胆酸促进肠道癌变中的血管生成拟态形成。
Cancer Sci. 2022 Feb;113(2):459-477. doi: 10.1111/cas.15208. Epub 2021 Dec 6.
10
New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.新型肽-药物偶联物用于精准靶向三阴乳腺癌来源的MDA-MB-231乳腺癌细胞和卵巢透明细胞癌ES-2细胞肿瘤微环境中SORT1介导的血管生成拟态。
Front Oncol. 2021 Oct 22;11:760787. doi: 10.3389/fonc.2021.760787. eCollection 2021.
Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.
表没食子儿茶素没食子酸酯(EGCG)在低氧状态下通过下调缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)对胃癌SGC7901细胞增殖和凋亡的影响
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):155-161. doi: 10.26355/eurrev_201901_16759.
4
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.重楼皂苷 I 通过 Twist1/VE-cadherin 通路抑制血管生成拟态的形成。
Cell Death Dis. 2018 Sep 5;9(9):906. doi: 10.1038/s41419-018-0902-5.
5
Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells.双氢青蒿素通过抑制肝细胞癌SK-Hep-1细胞中的特异性蛋白1途径诱导半胱天冬酶依赖性凋亡。
Life Sci. 2018 Jan 1;192:286-292. doi: 10.1016/j.lfs.2017.11.008. Epub 2017 Nov 8.
6
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression.EphA2非经典通路在癌症进展中的新功能及多样功能
Biol Pharm Bull. 2017;40(10):1616-1624. doi: 10.1248/bpb.b17-00446.
7
Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.表没食子儿茶素没食子酸酯(EGCG)在心血管和代谢疾病中的分子机制研究。
J Ethnopharmacol. 2018 Jan 10;210:296-310. doi: 10.1016/j.jep.2017.08.035. Epub 2017 Aug 31.
8
HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.低氧诱导因子-2α通过调节Twist1与血管内皮钙黏蛋白启动子的结合来促进胰腺癌中血管生成拟态的形成。
Oncotarget. 2017 Jul 18;8(29):47801-47815. doi: 10.18632/oncotarget.17999.
9
Therapeutic effects of EGCG: a patent review.表没食子儿茶素没食子酸酯的治疗作用:一项专利综述。
Expert Opin Ther Pat. 2016 Aug;26(8):907-16. doi: 10.1080/13543776.2016.1203419. Epub 2016 Jun 29.
10
The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.血管生成拟态与上皮-间质转化之间的关系。
J Cell Mol Med. 2016 Sep;20(9):1761-9. doi: 10.1111/jcmm.12851. Epub 2016 Mar 29.